Department of Biological Sciences, Pittsburgh NMR Center for Biomedical Research, and Center for Light Microscope Imaging and Biotechnology, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The function of creatine
kinase (CK) and its effect on phosphorus metabolites was studied in
livers of transgenic mice expressing human ubiquitous mitochondrial CK
(CK-Mit) and rat brain CK (CK-B) isoenzymes and their combination.
31P NMR spectroscopy and saturation transfer were recorded
in livers of anesthetized mice to measure high-energy phosphates and
hepatic CK activity. CK reaction velocity was related to total enzyme activity irrespective of the isoenzyme expressed, and it increased with increasing concentrations of creatine (Cr). The fluxes
mediated by both isoenzymes in both directions (phosphocreatine or ATP synthesis) were equal. Over a 20-fold increase in CK-Mit activity (28-560 µmol · g wet
wt1 · min
1), the fraction of
phosphorylated Cr increased 1.6-fold. Hepatic free ADP concentrations
calculated by assuming equilibrium of the CK-catalyzed reaction in vivo
decreased from 84 ± 9 to 38 ± 4 nmol/g wet wt. Calculated
free ADP levels in mice expressing high levels of CK-B (920-1,635
µmol · g wet wt
1 · min
1)
were 52 ± 6 nmol/g wet wt. Mice expressing both isoenzymes had calculated free ADP levels of 36 ± 4 nmol/g wet wt. These
findings indicate that CK-Mit catalyzes its reaction equally well in
both directions and can lower hepatic apparent free ADP concentrations.
mitochondrial creatine kinase; cytosolic creatine kinase; phosphorus-31 nuclear magnetic resonance spectroscopy; magnetization transfer; liver adenosine 5'-diphosphate concentration
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
CREATINE
KINASE (CK) catalyzes the transfer of high-energy
phosphate between phosphocreatine (PCr) and MgATP. This reaction, PCr + MgADP + H+ MgATP + creatine (Cr),
is catalyzed in both directions by CK. In tissues with abundant CK,
such as skeletal muscle, heart, and brain, the rapid reaction
maintained by the enzyme (21) enables buffering of ADP,
ATP, and pH during periods when ATP utilization exceeds ATP production
by glycolysis and oxidative phosphorylation (50). In
mammals, five genes are known to encode four isoenzymes of CK. In
skeletal muscle the MM dimer of CK is predominant, in brain the BB
dimer is predominant, and heart contains the MM dimer and the MB
heterodimer. In addition to these cytosolic isoforms of CK, there is a
mitochondrial form of CK (CK-Mit) that localizes to the intermembranal
space of mitochondria. A sarcomeric form of CK-Mit is expressed in
heart and skeletal muscle, and a ubiquitous CK-Mit is expressed in
brain and other tissues (50). The specific CK isoenzyme
composition of a tissue depends on the developmental and functional
characteristics of the tissue. In the fetal stage, CK-BB is almost
exclusively expressed, whereas the CK-MM and CK-Mit isoenzymes are
features of differentiation (13, 44, 50). The expression
of CK-Mit has been correlated with the development of oxidative
capacity in heart and brain (9, 49), whereas levels of
CK-MM correlate with the glycolytic capacity of muscle (30). The pattern of expression of CK isoenzymes changes
during adaptation of muscle, with a decrease in CK-MM and an increase in CK-Mit with processes that convert fast-twitch toward slow-twitch muscle (37). Considering the simple reaction catalyzed by
CK, it is not yet clear why there is such a rich diversity in
expression of CK isoenzymes.
The most striking difference between CK isoenzymes is their different subcellular localization. CK-Mit localizes to the intermembrane space of mitochondria, where it has been proposed to make a complex with adenine nucleotide translocase (ANT) in the inner membrane and porin in the outer membrane (1, 23, 32, 34). CK-MM and CK-BB are predominantly cytosolic but also show patterns of subcellular localization. CK-MM localizes to the outer face of sarcoplasmic reticulum and to myofibrils, whereas CK-BB has been localized to the plasma membrane and mitotic spindles (10, 31, 35, 38). The pattern of subcellular localization of CK has led to a model, referred to as the PCr circuit or shuttle hypothesis, that postulates coupling of CK-Mit to mitochondrial ATP generation and coupling of CK-MM (or CK-MB or CK-BB depending on the tissue) to ATP utilization (4, 50). The specific localization of CK is thought to buffer against local changes in ATP/ADP levels as well as to affect ATP/ADP delivery, production, and utilization. In particular, there has been a great deal of work studying the role of CK-Mit. Two main sources of experimental evidence support an important role for CK-Mit in coupling alterations in ADP to changes in ATP production by oxidative phosphorylation. First, extensive localization of the enzyme indicates that it is localized at contact sites of the inner and outer mitochondrial membrane in close association with porin and ANT (1, 24, 32, 34, 50). Second, a great deal of biochemical work indicates that ATP made by mitochondria is directly coupled to PCr generation and that the ADP produced is coupled to transport back into the mitochondrial matrix. In isolated mitochondria this coupling results in a lowering of the apparent Km of oxidative phosphorylation for ADP and eliminates the need to transport adenine nucleotides across the outer mitochondrial membrane (49). Evidence indicates that the outer mitochondrial membrane acts as a permeability barrier for ADP (33).
Despite extensive biochemical studies implicating CK-Mit in affecting mitochondrial function, there is little direct in vivo evidence for an important specific role of CK-Mit. Recently both the ubiquitous and sarcomeric forms of CK-Mit have been knocked out in mice. No obvious phenotypes are associated with loss of CK-Mit function (40, 41). There is evidence that elimination of CK causes adaptation of mitochondria, which may mask any direct effects of eliminating CK (49). An alternative strategy is to add CK-Mit to a tissue that does not normally contain it, such as the liver, to determine whether there is a gain of function effects. Recently, a transgenic mouse model has been produced that expresses active CK-Mit in liver (22). The CK-Mit localizes properly to the intermembrane space of mitochondria and is capable of synthesizing and utilizing PCr. These livers complement another set of transgenic mice that have been generated, which express the cytosolic CK-BB, enabling a direct comparison of changes in energy metabolism that may occur as a result of addition of different CK isoforms (18). An advantage of our approach of CK expression in the liver is the possibility of CK activation with dietary supplementation of Cr. Thus hepatic metabolism may be studied in the absence and presence of an active PCr circuit. In CK-BB-expressing livers no variation in free ADP levels was found over a wide range of enzyme activity and over a wide range of Cr levels (6). In the present work we used 31P NMR techniques to monitor the kinetics of CK in livers expressing CK-Mit and CK-BB. Contrary to a version of the shuttle hypothesis, CK-Mit catalyzes a reversible reaction, indicating that it is not perfectly coupled to the net flux of adenine nucleotides through the translocase. However, apparent free ADP levels drop with increasing activity of CK-Mit, even in the presence of CK-BB. These results indicate that CK-Mit can modulate mitochondrial function in vivo in an isoenzyme-specific manner.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Animal preparation.
Normal mice were a colony of inbred
B6D2F1 (originally obtained from
Taconic Farms, Germantown, NY). Transgenic mice expressing the human
ubiquitous CK-Mit or rat brain CK-BB isoenzymes in their livers were
created by incorporation of DNA fragments encoding for the proper CK
isoenzyme under transcriptional control of the liver-specific
transthyretin promoter as previously described (19, 22).
Three homozygous lines of CK-Mit-expressing mice, Mit77, Mit33, and
Mit11, expressed the enzyme at levels of 28, 483, and 560 µmol · g wet wt1 · min
1,
respectively. These mice were inbred with controls to generate heterozygotes for CK-Mit to further vary the level of enzyme
expression. To create mice that were heterozygous for CK-BB and CK-Mit,
homozygous lines of CK-BB and CK-Mit were inbred. These mice are
referred to as CK-combined (CK-Comb) mice to indicate that they are
expressing a combination of CK-BB and CK-Mit.
CK activity and isoenzyme distribution.
CK activity (demonstrated by maximum PCr recovery rate,
Vmax) was determined in homogenized tissue samples that
were diluted 1:1,000 with an extraction buffer containing 26 mM Tris,
0.3 mM sucrose, 20 mM -mercaptoethanol and 1%
tert-octophenyl poly(oxyethylene)ethanol (IGEPAL CA-630).
All materials were obtained from Sigma. Total CK activity was
determined spectrophotometrically at 37°C with a coupled
hexokinase-glucose 6-phosphate dehydrogenase enzymatic system
(procedure 45-UV; Sigma Diagnostics, St. Louis, MO). Diadenosine pentaphosphate (20 nM) was added to the reaction to inhibit adenylate kinase activity. Distribution of CK isoenzymes in CK-Comb mice was
determined with Multitrac CK electrophoretic isoenzyme gels (Ciba-Corning, Marshfield, MA). Tissue homogenates were diluted 1:200
with the extraction buffer, and 1.0-µl samples were applied to the
agarose gel. After color development, gels were scanned and
relative intensities were determined as previously described (8).
NMR spectroscopy.
Spectra were recorded with a Bruker 300-MHz spectrometer with
15-cm-wide horizontal bore magnet operating at 121.5 MHz for 31P. In vivo NMR spectra were collected with a 6-mm
two-turn surface coil. Spectra were obtained by averaging 50 transients
with a repetition time of 10 s. Free induction decays were
multiplied with a 20-Hz line-broadening function, and peak integrals
were measured with the Bruker integration subroutine. An external
reference containing 4 µmol of methylphosphonic acid (MPA) and 12 µmol of gadolinium diethylenetriamine pentaacetic acid in 145 mM NaCl solution was used to compare phosphorus metabolites contents in each
experimental group and in livers of transgenic and normal mice. An ATP
concentration of 4 µmol/g wet wt was adopted from previous studies of
livers of transgenic mice with HPLC and NMR to determine phosphorus
metabolite concentrations (6, 7). Intracellular pH was
measured from the chemical shift of Pi from PCr
according to the relationship determined by Bailey et al. (3). Intracellular free magnesium concentration
([Mg2+]free) was estimated from the
chemical shift of -ATP from
-ATP according to the relationship
determined by Murphy et al. (25).
Determination of Cr levels. Intrahepatic total Cr (Cr + PCr) contents were determined form livers after NMR experiments. Liver samples were diluted with 5 vols of 5% perchloric acid and homogenized. Samples were centrifuged at 10,000 g for 15 min at 4°C, and the supernatant was neutralized with KOH. Samples were centrifuged at 15,000 g for 15 min at 4°C. The pH of the supernatant was adjusted to pH 7.0 and lyophilized to dryness. Samples were dissolved in 2H2O containing 2 mM EGTA and 1 µmol of trimethylsylil propionic acid (TSP). 1H NMR spectra of tissue perchloric acid extracts were recorded on a Bruker 300-MHz NMR spectrometer operating at 300.13 MHz for 1H NMR. Spectra were acquisitions of eight transients with a repetition time of 8 s. Peaks were assigned and quantified using TSP as an internal reference. The methyl group of Cr + PCr was detected at 3.0 ± 0.1 ppm at pH 7.0 ± 0.6.
Calculation of free ADP levels. Apparent ADP levels were determined by assuming that the CK present in the liver catalyzed an equilibrium reaction. Because metabolite levels were in a steady state and no other reaction is known to produce or utilize PCr, this is a reasonable assumption. The expression ADP = ([ATP][Cr])/([PCr][H+]Keq), with an apparent equilibrium rate constant (Keq) = 1.58 × 109 at pH = 7.24 and [Mg2+]free = 0.65, was used (21). ATP levels were assumed to be 4.0 µmol/g wet wt. PCr levels were calculated from the PCr-to-ATP ratios determined from 31P NMR spectra, and Cr levels were determined from the difference in total Cr determined from tissue extracts by 1H NMR and the PCr levels determined from 31P NMR. ADP is reported in units of nanomoles per gram of wet weight and represents the sum of all ionic species of ADP.
Calculation of CK reaction rates. Enzyme flux was calculated with the equation derived to predict steady-state rates in reference to Vmax (18, 20): Vfor = (Vmax × [ADP] × [PCr])/[D × Km(ADP) × Kd(PCr)]. Vmax, [PCr], and [ADP] were measured as described above, and D is the sum of terms expressing metabolite concentrations divided by Kd and Km, the binary and ternary substrate-enzyme complexes, respectively, adopted from values reported for CK-Mit reaction in vitro (46).
CS and HK activities. Citrate synthase (CS) was extracted with a buffer containing 0.225 M mannitol and 0.075 M fructose in tissue homogenates. CS activity was measured spectrophotometrically at 37°C with a malate dehydrogenase-coupled reaction in a medium containing 10 mM oxaloacetate, 1 mM Ellman's reagent, 10 mM acetyl-CoA, and 10% Triton X-100 (29). Hexokinase (HK) was determined spectrophotometrically with a glucose-6-phosphate-coupled reaction in a medium containing 0.1 M Tris, 5 mM MgCl2, 2 mM glucose, 5 mM ATP, 0.5 mM NADP, 0.05% bovine serum albumin, and 0.5% Triton X-100 (29).
Tissue water contents.
Tissue water (tw) contents were determined from the dry (dw) and wet
(ww) weights of liver samples according to tw = (ww dw)/dw. Dry weights were measured after 24 h at 85°C. Molar
concentrations were calculated by assuming a ratio of intra- to
extracellular water of 2/1 (28, 42).
Data analysis. All results are presented as means ± SD. Statistical significance was accepted at P < 0.05 by Student's t-test.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Mice expressing hepatic CK-Mit and CK-BB have been described
previously (6, 8, 17, 18). It was possible to generate mice with a wide variety of CK-Mit activities by using the different lines of transgenic mice previously generated. Table
1 lists the different mice used, the
genotypes, and Vmax CK activities determined in
tissue extracts. Values represent means ± SD of groups of mice
(n = 10). CK-Mit activity ranged from 28 to 560 µmol · g wet wt1 · min
1
in five lines of mice. CK-BB activities were 920 ± 112 and
1,635 ± 172 µmol · g wet
wt
1 · min
1 in the lines chosen for
this study. Finally, CK-Comb mice were generated by interbreeding the
homozygous CK-BB line with the homozygous Mit33 line. Total activity in
CK-Comb was 1,135 ± 134 µmol · g wet
wt
1 · min
1 with ~305
µmol · g wet wt
1 · min
1
(27%) due to CK-Mit and 830 µmol · g wet
wt
1 · min
1 (73%) due to CK-BB.
|
31P NMR spectra indicated that a large amount of PCr was
generated in livers expressing CK-BB and CK-Mit compared with control livers (Fig. 1). With the MPA standard,
it was determined that ATP levels were not different among the
different lines of transgenic mice (data not shown). To determine the
in vivo rates of CK in the various livers, saturation transfer was
performed. Fig. 2 shows representative
spectra used to measure kfor from the CK-BB line
of mice. In this case, saturation of -ATP (Fig. 2B) led to a decrease in PCr compared with control irradiation (Fig.
2A) as clearly shown in the difference spectrum (Fig.
2C). Figure 3A
shows that over the range of CK activities there was a linear relation
between the CK rate measured in vivo with saturation transfer NMR and
Vmax activities determined from extracts. The rate of CK measured in vivo was, in part, determined by Cr levels as
shown in Fig. 3B. There was a linear increase in rate with increase in Cr. Detailed kinetic parameters are difficult to obtain in
these experiments because PCr levels and ADP levels changed in addition
to changes in Cr. However, the results obtained are in rough agreement
with the in vitro measured values of Km of CK-BB
and CK-Mit for Cr (46).
|
|
|
Table 2 shows data obtained for
kfor from all the mice and
krev from some of the mice (n = 6 in each group). It can be clearly seen that CK-Mit mice with
significant levels of CK catalyze a detectable reaction in both
directions. If the forward rates of the CK reaction were equal to the
reverse rates, the ratio of kfor/krev should be equal
to the ATP-to-PCr ratios. This comparison is also shown in Table 2. For
all of the mice evaluated there is good agreement between the ratio of
metabolites and the ratio of rate constants, indicating that even
though CK-Mit is localized to the inner mitochondrial membrane, it is
able to catalyze its reaction at approximately equal rates in both
directions.
|
Recently it was shown in vitro in hearts that the forward rate of the
reaction catalyzed by CK-Mit can be adequately described by the
enzyme's rate equation if the concentration of substrates is known
(46). To test whether the measured and calculated
concentrations of metabolites were consistent with the saturation
transfer data, the measured forward rate of the CK-Mit catalyzed
reaction ([PCr] × kfor) was compared with
that predicted from the measured metabolites. Table
3 shows that over the full range of
CK-Mit activities there is excellent agreement between the measured
(n = 6) and predicted forward rates catalyzed by
CK-Mit.
|
To check whether the presence of CK-Mit affected cellular energetics,
free ADP levels were calculated in the various livers. Phosphorus
spectra were collected in the presence of an external reference used to
calibrate the peak integrals (Fig. 1). The apparent ATP contents of
livers, within the experimental limitations of the surface coil, were
stable in livers expressing various activities of both CK isoenzymes.
Tissue PCr contents were determined by assuming an ATP concentration of
4 µmol/g wet wt. Total Cr (PCr + Cr) was determined from
1H NMR spectra of tissue extracts, enabling Cr levels to be
calculated from the difference in total Cr and PCr levels. Table
4 presents values of Cr and PCr for
livers of the different mice (n = 9). Free ADP levels
were calculated by assuming equilibrium of the CK reaction and constant
pH and [Mg2+]free. These values were similar
in all the transgenic mouse livers with mean values of pH = 7.24 ± 0.04 and [Mg2+]free = 0.65 ± 0.06 mM (data not shown).
|
Interestingly, there is a variation in ADP levels with activity of
CK-Mit. Calculated ADP concentrations are plotted against total CK
activity in Fig. 4. The calculated ADP
concentrations decreased as a function of Vmax
in livers expressing CK-Mit. Calculated ADP levels fell from 84 nmol/g
wet wt in Mit77 mice to 38 nmol/g wet wt in Mit11 mice. Decreasing the
total Cr by reducing dietary Cr had no significant effects on the
calculated ADP levels. Assuming an intracellular water-to-extracellular
water ratio of 2/1, molar concentrations of ADP ranged from 128 to 54 µM. The differential uptake of Cr in livers with various CK
activities may have increased the ratio of intra- to extracellular
water, resulting in overestimation of the molar concentrations of ADP.
Mice expressing two levels of CK-BB had intermediate ADP levels of
~52 nmol/g wet wt (78 µM). Previous results varying CK-BB activity
over a wide range did not detect differences in calculated ADP
(6), consistent with values similar to those found here
over a twofold range of CK-BB activity. Interestingly, livers
expressing both CK-BB and CK-Mit had low levels of ADP consistent with
the levels determined from livers expressing CK-Mit only.
|
The relatively large changes in ADP associated with expression of
CK-Mit in the liver might be expected to cause adaptation of liver
metabolism. To begin to address this issue, levels of CS and HK were
measured (n = 6) in control and CK-Mit-expressing livers (Table 5). After 4 days of 5% Cr
feeding, CS activity tended to decrease with increasing activities of
CK-Mit (y = 131 0.07x;
r2 = 0.74; P < 0.05). A
similar change was observed in HK activity as CK-Mit activity increased
(y = 2.2
0.0001x;
r2 = 0.96; P < 0.005). These results
indicate that the calculated change in ADP has functional consequences
for hepatic metabolic capacities.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The present work makes two important contributions to the understanding of the function of CK-Mit. The first contribution is the demonstration that CK-Mit can cause a decrease in apparent levels of ADP. ADP concentrations calculated assuming CK equilibrium ranged from as high as 84 ± 9 nmol/g wet wt in livers with low levels of CK-Mit to as low as 38 ± 4 nmol/g wet wt in livers with the highest levels of CK-Mit. This calculation was based on whole liver measured values of the indicator metabolites PCr, Cr, ATP, pH, and Mg2+. A number of arguments indicate that ADP levels were lowered by functional incorporation of CK-Mit in livers of the transgenic mice. First, the predicted fluxes for CK-Mit based on the measured metabolites matched the measured values very closely (Table 3). Second, ADP concentrations were similar at different dietary Cr concentrations, indicating adjustment of indicator metabolite concentrations according to the CK equilibrium (Table 4). Third, in mice expressing both CK-Mit and CK-B (CK-Comb mice) there was a significant decrease in apparent ADP levels (Table 4). Evidently CK-Mit was the dominant factor in determination of ADP concentration in livers of CK-Comb mice, within the range of ADP levels in CK-Mit mice. Fourth, there were decreases in measured levels of citrate synthase and hexokinase, indicating that the liver was adapting to a change in energetics, as might be expected if ADP levels were lower in the livers expressing CK-Mit (Table 5).
The results comparing calculated ADP levels in the various mice open the question of what the free ADP level is in a normal liver. 31P NMR estimates put it at ~200 nmol/g wet wt (11, 12, 16). These results are difficult because of the low levels for NMR sensitivities and the fact that differences between peaks must be monitored (43). Assuming that glycolysis maintains equilibrium through three steps, a value of free ADP of 50 nmol/g wet wt has been reported (47). This work relied on determination of a number of indicator metabolites, and it is likely that levels of free Pi were overestimated, leading to an underestimate of free ADP levels. In our own work expressing CK-BB in liver, we have measured free ADP levels of ~50 nmol/g wet wt over a wide range of CK activity and Cr concentration (6, 18). However, in these studies the lowest enzyme activities were higher than the highest CK-Mit activities in the present work, indicating that any decreases in ADP caused by CK-BB may have been saturated even at the lowest activities. The high level of ADP (84 ± 9 nmol/g wet wt) obtained in the lowest CK-Mit-expressing livers indicates that both CK-B and CK-Mit have lowered hepatic ADP levels compared with normal livers. Indeed, extrapolation of the apparent ADP levels to zero CK activity gives values of ~135 µM, consistent with the NMR results from normal livers (11, 12, 16). Thus it may be that both CK-B and CK-Mit decrease hepatic ADP levels; however, it is clear that CK-Mit is able to maintain lower levels of ADP than CK-B.
There are a number of possible mechanisms whereby CK-Mit could cause decreases in ADP levels in liver. Most in vitro work demonstrates that the presence of CK-Mit causes a decrease in the Km of ADP for oxidative phosphorylation (unpublished data). No significant differences in oxygen consumption rates have been measured in perfused livers expressing CK-Mit compared with normal livers (unpublished data). Assuming that rates of oxidative phosphorylation are the same in transgenic livers expressing varying levels of CK-Mit and CK-B, these rates can be supported by lower levels of ADP in livers with high levels of CK-Mit, thus enabling them to maintain lower ADP levels. These findings corroborate previous observations that mitochondria isolated from mice expressing CK-Mit had higher rates of respiration at submaximal levels of ADP (27). Consistent with the notion that CK-Mit can modulate the Km of oxidative phosphorylation for ADP is the finding that increases in cardiac work cause larger changes in ADP in hearts lacking CK-Mit and CK-MM for a similar change in oxygen consumption (36). Interestingly, levels of ADP were the same in hearts lacking CK-Mit and CK-MM compared with control at low levels of work (36, 48). Experiments that use fructose to increase hepatic ADP and oxygen consumption should enable direct quantification of the Km of ADP for oxidative phosphorylation in transgenic livers (7).
There are possibilities for how CK-Mit might lower ADP levels other than affecting the relation between oxidative phosphorylation and ADP. Recently, imaging studies of single mitochondria indicate that there is spontaneous depolarization of mitochondria caused by opening of the mitochondrial permeability transition pore (MPT; Ref. 15). There is evidence that the MPT is the ANT. If liver mitochondria are spontaneously depolarizing at a significant rate one would expect higher levels of ADP than if they depolarized at a slower rate. Recent studies on mitochondria isolated from CK-Mit-expressing livers indicates that CK-Mit can inhibit the MPT, which in turn could lead to lower levels of cellular ADP (27).
Finally, it may be that substrate utilization by mitochondria is affected by CK-Mit. Tissues with high levels of CK-Mit, such as heart, tend to rely on fatty acids as the primary substrate for oxidative phosphorylation, whereas tissues with low levels of CK-Mit, such as brain or skeletal muscle, tend to rely on carbohydrates. Although it is difficult to imagine a direct connection between CK-Mit levels and mitochondrial substrate utilization, it may be that changes in ADP levels alter substrate utilization, which can in turn affect ADP levels. Preliminary results indicate that mouse livers expressing CK-Mit are more sensitive to inhibitors of mitochondrial fatty acid transport than normal or CK-B-expressing livers (unpublished observation).
The other important finding of the present work is that 31P NMR rate measurements of CK isoenzymes expressed in transgenic livers indicate that the net forward fluxes were approximately equal to the reverse fluxes. This result was expected in steady-state metabolic conditions in livers expressing one of the isoenzymes, indicating catalysis of Pi transfer between ADP and Cr at equal rates. We also measured equal fluxes in CK-Comb livers expressing both CK isoenzymes. Reversible Pi transfer at equal rates was demonstrated in vitro (46), with ex vivo stimulation of slow twitch muscle (22) and in vivo during a maturational increase in CK activity in the mouse brain (14). However, other in vivo studies have reported Vfor-to-Vrev ratios of 2-2.4 in tissues with variable composition of CK isoenzymes, including brain, heart, and skeletal muscle (5, 26, 39, 45). The experimental explanation given to this phenomenon was incomplete detection of the exchange of NMR-invisible metabolites because of intracellular compartmentation (19) and participation of ATP in multiple phosphorus transfer reactions, whereas PCr transfers its high-energy phosphate solely to ATP (45). Both explanations could be true in the case of the liver under baseline metabolic conditions. In the liver equal forward and reverse rates of saturation transfer may result from absolute NMR visibility of phosphorus metabolites, compartmentation of equal amounts of substrates, or exchange rates from ATP to PCr faster than the competing reactions.
The PCr shuttle hypothesis postulates that cytosolic and mitochondrial
CK isoenzymes form a close circuit of ATP synthesis in the cytosol and
hydrolysis in mitochondrial intermembrane space (1, 24, 32, 34,
50). This model would predict a much higher rate of CK-Mit in
the direction of ATP + Cr ADP + PCr. Considering that the
outer mitochondrial membrane leaflet is relatively impermeable to ADP
(33), ADP concentrations in mitochondrial intermembrane
space are higher (32) and CK-Mit is functionally coupled
to the ANT (24, 34, 50). According to this model, the flux
through CK-Mit should be equal or proportional to that through the ANT,
attributing a transport function to CK-Mit in addition to its energy
buffering activity in excitable tissues (1, 50). If the
main role of CK-Mit is to recycle nucleotides coupled to ANT activity
in mitochondrial intermembrane space, flux in the ADP-generating
direction (Vrev) should be higher than the
forward flux (Vfor).
We have measured roughly equal net fluxes in the forward and reverse directions over a wide range of CK-Mit activities, as expected from an enzyme operating at steady state. The measured CK fluxes could be predicted from the rate equation using the concentrations of participating metabolites, and there was a roughly linear relationship between the reaction velocity and total CK activity irrespective of the isoenzymes expressed by the livers. These findings indicate thermodynamic regulation of hepatic CK reaction velocity in the transgenic mice, lacking any vectorial predilection. Furthermore, in perfused livers the flux through CK-Mit was steady when oxygen consumption was increased by phenylephrine (unpublished data). This evidence argues against a strong coupling between CK-Mit and ANT that would create unequal net fluxes.
One may suggest that in the transgenic livers the human ubiquitous CK-Mit was not able to pair with the mouse ANT to form a strongly coupled system. We have evidence that in the transgenic livers ~93% of CK-Mit is associated with the mitochondrial membrane (23) and ADP concentrations are modulated by this isoenzyme in vivo. Furthermore, the presence of CK-Mit in the liver alters the sensitivity of mitochondrial respiration to changes in ADP and substrate preferences (unpublished data). Therefore, it is clear that CK-Mit catalyzes roughly equal forward and reverse rates of the reaction even though it is confined to the intermembrane space. We were unable to determine oxygen consumption in vivo; therefore, the flux through CK-Mit could be not related to ANT activity at various work loads.
In conclusion, expression of CK-Mit in transgenic livers led to an activity-dependent decrease in calculated ADP levels. This decrease in ADP occurred even in the presence of CK-B. This represents in vivo evidence that CK-Mit can have specific effects on cellular energetics. This CK-Mit effect may explain the recently observed effects of CK-Mit on cellular growth (2).
![]() |
ACKNOWLEDGEMENTS |
---|
The authors acknowledge Dr. Virgil Simplaceanu for assistance with NMR experiments and Kathy Sharer for assistance with the mice.
![]() |
FOOTNOTES |
---|
This work was supported by a National Heart, Lung, and Blood Institute (NHLBI) research career development award to A. P. Koretsky (HL-02847), NHLBI Grant R01-HL-40354, and a postdoctoral fellowship from the Pennsylvania Affiliate of the American Heart Association to N. Askenasy.
Address for reprint requests and other correspondence: N. Askenasy, Box 164, Mellon Institute, 4400 Fifth Ave, Pittsburgh, PA 15213 (E-mail: askenasy+{at}andrew.cmu.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published October 3, 2001; 10.1152/ajpcell.00404.2001
Received 17 August 2001; accepted in final form 1 October 2001.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Aliev, MK,
van Dorsten FA,
Nederhoff MG,
van Echteld CJ,
Veksler V,
Nikolay K,
and
Saks VA.
Mathematical model of compartmentalized energy transfer: its use for analysis and interpretation of 31P-NMR studies of isolated heart of creatine kinase deficient mice.
Mol Cell Biochem
184:
209-229,
1998[ISI][Medline].
2.
Askenasy, N,
and
Koretsky AP.
Differential effects of creatine kinase isoenzymes and substrates on regeneration in livers transgenic mice.
Am J Physiol Cell Physiol
273:
C741-C746,
1997
3.
Bailey, IA,
Williams SR,
Radda GK,
and
Gadian DG.
The activity of phosphorylase in total global ischemia in the rat heart: a phosphorus-31 nuclear magnetic resonance study.
Biochem J
196:
171-178,
1981[ISI][Medline].
4.
Bessman, SP,
and
Geiger PJ.
Transport of energy in muscle: the phosphorylcreatine shuttle.
Science
211:
448-452,
1981[ISI][Medline].
5.
Bittl, JA,
DeLayre J,
and
Ingwall JS.
Rate equation for creatine kinase predicts the in vivo reaction velocity: 31P NMR surface coil studies in brain, heart, and skeletal muscle of the living rat.
Biochemistry
26:
6083-6090,
1987[ISI][Medline].
6.
Brosnan, MJ,
Chen L,
Van Dyke TA,
and
Koretsky AP.
Free ADP levels in transgenic mouse liver expressing creatine kinase: effects of enzyme activity, phosphagen type, and substrate concentration.
J Biol Chem
265:
20849-20855,
1990
7.
Brosnan, JM,
Chen L,
Wheeler CE,
Van Dyke TA,
and
Koretsky AP.
Phosphocreatine protects ATP from a fructose load in transgenic mouse liver expressing creatine kinase.
Am J Physiol Cell Physiol
260:
C1191-C1200,
1991
8.
Brosnan, MJ,
Raman SP,
Chen L,
and
Koretsky AP.
Altering creatine kinase isoenzymes in transgenic mouse muscle by overexpression of the B subunit.
Am J Physiol Cell Physiol
264:
C151-C160,
1993
9.
Booth, RF,
and
Clark JB.
Studies on the mitochondrially bound form of rat brain creatine kinase.
Biochem J
170:
145-151,
1978[ISI][Medline].
10.
Cande, WZ.
Creatine kinase role in anaphase chromosome movement.
Nature
304:
557-558,
1983[ISI][Medline].
11.
Cohen, SM.
Application of nuclear magnetic resonance to the study of liver physiology and disease.
Hepatology
3:
738-749,
1983[ISI][Medline].
12.
Cunningham, CC,
Malloy CR,
and
Radda GK.
Effect of fasting and acute ethanol administration on the energy state of in vivo liver as measured by 31P-NMR spectroscopy.
Biochim Biophys Acta
885:
12-22,
1986[ISI][Medline].
13.
Hall, N,
and
DeLuca M.
Developmental changes in creatine phosphokinase isoenzymes in neonatal mouse hearts.
Biochem Biophys Res Commun
66:
988-994,
1975[ISI][Medline].
14.
Holtzman, D,
McFarland EW,
Jacobs D,
Offutt MC,
and
Neuringer LJ.
Maturational increase in mouse brain creatine kinase reaction rates shown by phosphorus magnetic resonance.
Brain Res Dev Brain Res
58:
181-188,
1991[ISI][Medline].
15.
Huser, J,
Rechenmacher E,
and
Blatter LA.
Imaging the permeability pore transition in single mitochondria.
Biophys J
74:
2129-2137,
1998
16.
Iles, RA,
Stevens AN,
Griffiths JR,
and
Morris PG.
Phosphorylation status of liver by 31P-n.m.r. spectroscopy, and its implications for metabolic control A comparison of 31P-n.m.r. spectroscopy (in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP and Pi.
Biochem J
229:
141-151,
1985[ISI][Medline].
17.
Koretsky, AP,
Brosnan ML,
Chen L,
Chen J,
and
Van Dyke TA.
NMR detection of creatine kinase expressed in liver of transgenic mice: determination of free ADP levels.
Proc Natl Acad Sci USA
87:
3112-3116,
1990[Abstract].
18.
Koretsky, AP,
Miller KR,
and
Halow JM.
Hepatic energy phosphate metabolism in transgenic livers expressing creatine kinase as revealed by 31P NMR.
Adv Mol Cell Biol
11:
233-255,
1995.
19.
Koretsky, AP,
and
Weiner MW.
31P NMR magnetization transfer measurement of phosphorus reactions.
In: Biomedical Magnetic Resonance, edited by Margulis A,
and James TL.. San Francisco, CA: Radiology Research and Education Foundation, 1984, p. 209-230.
20.
Kupriyanov, VV,
Steinscheider AY,
Ruuge EK,
Kapelko VI,
Zueva MY,
and
Saks VA.
Regulation of energy flux through the creatine kinase reaction in vitro and in perfused rat heart. 31P-NMR studies.
Biochim Biophys Acta
805:
319-331,
1984[ISI][Medline].
21.
Lawson, JWR,
and
Veech RL.
Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions.
J Biol Chem
254:
6528-6537,
1979[Abstract].
22.
McFarland, EW,
Kushmerick MJ,
and
Moerland TS.
Activity of creatine kinase in a contracting mammalian muscle of uniform fiber type.
Biophys J
67:
1912-1924,
1994[Abstract].
23.
Miller, K,
Sharer K,
Suhan J,
and
Koretsky AP.
Expression of functional mitochondrial creatine kinase in liver of transgenic mice.
Am J Physiol Cell Physiol
272:
C1193-C1202,
1997
24.
Moreadith, RW,
and
Jacobus WE.
Creatine kinase of heart mitochondria: functional coupling of ADP transfer to the adenine nucleotide translocase.
J Biol Chem
57:
899-905,
1982.
25.
Murphy, E,
Steenbergen C,
Levy L,
and
London RE.
Cytosolic free magnesium levels in ischemic rat heart.
J Biol Chem
264:
5622-5627,
1989
26.
Nunnally, RL,
and
Hollis DP.
Adenosine triphosphate compartmentation in living hearts: a phosphorus nuclear magnetic resonance saturation transfer study.
Biochemistry
18:
3642-3646,
1979[ISI][Medline].
27.
O'Gorman, E,
Beatner G,
Dolder M,
Koretsky A,
Brdiczka D,
and
Wallimann T.
The role of creatine kinase in inhibition of mitochondrial permeability transition.
FEBS Lett
414:
253-257,
1997[ISI][Medline].
28.
Pang, KS,
Barker F,
Schwab AJ,
and
Goresky CA.
[14C]urea and 58Co-EDTA as reference indicators in hepatic multiple indicator dilution studies.
Am J Physiol Gastrointest Liver Physiol
259:
G32-G40,
1990
29.
Passonneau, JV,
and
Lowry OH.
Enzymatic Analysis Totowa, NJ: Humana, 1993, p. 244-273.
30.
Perry, SB,
McAuliffe J,
Balschi JA,
Hickey PR,
and
Ingwall JS.
Velocity of creatine kinase reaction in the neonatal rabbit heart: role of mitochondrial creatine kinase.
Biochemistry
27:
2165-2172,
1988[ISI][Medline].
31.
Rossi, AM,
Eppenberger HM,
Vopel P,
Cotrufo R,
and
Wallimann T.
Muscle-type MM creatine kinase is specifically bound to sarcoplasmic reticulum and can support Ca2+ uptake and regulate local ATP/ADP ratios.
J Biol Chem
265:
5258-5266,
1990
32.
Saks, V,
Dos Santos P,
Gellerich FN,
and
Diolez P.
Quantitative studies of enzyme-substrate compartmentation, functional coupling and metabolic channeling in muscle cells.
Mol Cell Biochem
184:
291-307,
1998[ISI][Medline].
33.
Saks, VA,
Kuznetsov AV,
Khuchua ZA,
Vasilyeva EV,
Bekikova JO,
Kesvatera T,
and
Tiivel T.
Control of cellular respiration in vivo by mitochondrial outer membrane and by creatine kinase. A new speculative hypothesis: possible involvement of mitochondrial-cytoskeleton interactions.
J Mol Cell Cardiol
27:
625-645,
1995[ISI][Medline].
34.
Saks, VA,
Lipina NV,
Smirnov VN,
and
Chazov EI.
Studies of energy transport in heart cells: the functional coupling between mitochondrial phosphokinase and ATP-ADP translocase.
Arch Biochem Biophys
173:
34-31,
1976[ISI][Medline].
35.
Saks, VA,
Rosenshtraukh LV,
Smirnov VN,
and
Chazov EI.
Role of creatine phosphokinase in cellular function and metabolism.
Can J Physiol Pharmacol
56:
691-706,
1978[ISI][Medline].
36.
Saupe, KW,
Spindler M,
Tian R,
and
Ingwall JS.
Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase.
Circ Res
82:
898-907,
1998
37.
Schmitt, T,
and
Pette D.
Increased mitochondrial creatine kinase in chronically stimulated fast twitch rabbit muscle.
FEBS Lett
188:
341-344,
1985[ISI][Medline].
38.
Sharov, VG,
Saks VA,
Smirnov VM,
and
Chazov EI.
An electron microscopic histochemical investigation of the localization of creatine phosphokinase in heart cells.
Biochim Biophys Acta
468:
495-501,
1977[ISI][Medline].
39.
Shoubridge, EA,
Briggs RW,
and
Rada GK.
31P NMR saturation transfer measurements of the steady state rates of creatine kinase and synthetase in the rat brain.
FEBS Lett
140:
288-292,
1982[ISI].
40.
Steeghs, K,
Oerlemans F,
deHaan A,
Heerschap A,
Verdoodt L,
deBie M,
Ruitenbeek W,
Benders A,
Jost C,
van Deursen J,
Tullson P,
Terjung R,
Jap P,
Jacob W,
Pette D,
and
Wieringa B.
Cytoarchitectural and metabolic adaptations in muscles with mitochondrial and cytosolic creatine kinase deficiencies.
Mol Cell Biochem
184:
183-194,
1998[ISI][Medline].
41.
Steeghs, K,
Oerlemans F,
and
Wieringa B.
Mice deficient in ubiquitous mitochondrial creatine kinase are viable and fertile.
Biochim Biophys Acta
1230:
130-138,
1995[ISI][Medline].
42.
Suzuki-Kemmelmeier, F,
Ishii-Iwamoto EL,
and
Bracht A.
The metabolism of fructose in the bivascularly perfused rat liver.
Biochim Biophys Acta
1116:
275-282,
1992[ISI][Medline].
43.
Tanaka, A,
Chance B,
and
Quistorff B.
A possible role of inorganic phosphate as a regulator of oxidative phosphorylation in combined urea synthesis and gluconeogenesis in perfused rat liver.
J Biol Chem
264:
10034-10040,
1989
44.
Trask, RV,
Strauss AW,
and
Billadello JJ.
Developmental regulation of tissue specific expression of the human muscle creatine kinase gene.
J Biol Chem
263:
17142-17149,
1988
45.
Ugurbil, K,
Petein M,
Maidan R,
Michurski S,
and
From AH.
Measurement of an individual rate constant in the presence of multiple exchanges: application to myocardial creatine kinase reaction.
Biochemistry
25:
100-107,
1986[ISI][Medline].
46.
Van Dorsten, FA,
Furter R,
Bijkerk M,
Wallimann T,
and
Nicolay K.
The in vitro kinetics of mitochondrial and cytosolic creatine kinase determined by saturation transfer 31P NMR.
Biochim Biophys Acta
1274:
59-66,
1996[ISI][Medline].
47.
Veech, RL,
Lawson JWR,
Cornell NW,
and
Krebs HA.
Cytosolic phosphorylation potential.
J Biol Chem
254:
6538-6547,
1979[Abstract].
48.
Veksler, VI,
Kuznetsov AV,
Anflous K,
Matoe P,
vanDeursen J,
Wieringa B,
and
Ventura-Clapier R.
Muscle creatine kinase-deficient mice. II. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function.
J Biol Chem
270:
19921-19929,
1995
49.
Ventura-Clapier, R,
Kuznetsov A,
Veksler V,
Boehm E,
and
Anflous K.
Functional coupling of creatine kinases in muscle: species and tissue specificity.
Mol Cell Biochem
184:
231-247,
1998[ISI][Medline].
50.
Wallimann, T,
Wyss M,
Brdiczka D,
Nicolay K,
and
Eppenberger HM.
Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis.
Biochem J
281:
21-40,
1992[ISI][Medline].